https://www.manilatimes.net/2026/06/30/tmt-newswire/globenewswire/vect-horus-announces-collaboration-and-license-option-agreement-with-servier-to-develop-targeted-oligonucleotide-therapeutics-for-rare-cns-diseases/2375405